Boothbay Fund Management, LLC Catalyst Biosciences, Inc. Transaction History

Boothbay Fund Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $16,529 - $81,728	-45,915 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $77,527 - $106,241	-20,510 Reduced 30.88%	45,915 $189,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $8,200 - $10,660	-2,000 Reduced 2.92%	66,425 $288,000
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $337,335 - $489,238	68,425 New	68,425 $345,000
Q3 2020 Nov 16, 2020	SELL	$4.22 - $6.04 $167,745 - $240,090	-39,750 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $149,460 - $318,397	39,750 New	39,750 $233,000
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $534,296 - $710,871	-57,144 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $296,002 - $938,368	32,492 Added 131.8%	57,144 $667,000
Q1 2018 May 14, 2018	BUY	$14.18 - $35.6 $349,565 - $877,611	24,652 New	24,652 $636,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.